109 related articles for article (PubMed ID: 24566498)
21. Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.
Hui CK; Cheung WW; Au WY; Lie AK; Zhang HY; Yueng YH; Wong BC; Leung N; Kwong YL; Liang R; Lau GK
Gut; 2005 Nov; 54(11):1597-603. PubMed ID: 16000641
[TBL] [Abstract][Full Text] [Related]
22. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
23. Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Lin CI; Lin ZY; Hsieh MY; Huang CF; Chen SH; Chuang WL
Kaohsiung J Med Sci; 2011 Dec; 27(12):554-9. PubMed ID: 22208538
[TBL] [Abstract][Full Text] [Related]
24. Urgent liver transplantation for chemotherapy-induced HBV reactivation: a suitable option in patients recently treated for malignant lymphoma.
Sperl J; Frankova S; Kieslichova E; Oliverius M; Janousek L; Honsova E; Trunecka P; Spicak J
Transplant Proc; 2013 Sep; 45(7):2834-7. PubMed ID: 24034061
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, beta-LPA.
He XX; Chen T; Lin JS; Chang Y; Ye BX
Biochem Biophys Res Commun; 2008 May; 369(2):513-8. PubMed ID: 18284916
[TBL] [Abstract][Full Text] [Related]
26. [A case of the usage of entecavir to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient].
Muraoka T; Taira N; Shien T; Doihara H; Takaki A; Miyoshi S
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1861-4. PubMed ID: 22083198
[TBL] [Abstract][Full Text] [Related]
27. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
28. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
[TBL] [Abstract][Full Text] [Related]
29. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
30. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Leaw SJ; Yen CJ; Huang WT; Chen TY; Su WC; Tsao CJ
Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression.
Chen YF; Chong CL; Wu YC; Wang YL; Tsai KN; Kuo TM; Hong MH; Hu CP; Chen ML; Chou YC; Chang C
PLoS One; 2015; 10(6):e0131743. PubMed ID: 26121644
[TBL] [Abstract][Full Text] [Related]
32. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
Jang JW; Choi JY; Bae SH; Kim CW; Yoon SK; Cho SH; Yang JM; Ahn BM; Lee CD; Lee YS; Chung KW; Sun HS
J Hepatol; 2004 Sep; 41(3):427-35. PubMed ID: 15336446
[TBL] [Abstract][Full Text] [Related]
33. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.
Sugauchi F; Tanaka Y; Kusumoto S; Matsuura K; Sugiyama M; Kurbanov F; Ueda R; Mizokami M
J Med Virol; 2011 Mar; 83(3):412-8. PubMed ID: 21264861
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppression and HBV reactivation.
Shouval D; Shibolet O
Semin Liver Dis; 2013 May; 33(2):167-77. PubMed ID: 23749673
[TBL] [Abstract][Full Text] [Related]
37. RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.
Wang J; Jia J; Chen R; Ding S; Xu Q; Zhang T; Chen X; Liu S; Lu F
Cancer Med; 2018 May; 7(5):2021-2033. PubMed ID: 29601674
[TBL] [Abstract][Full Text] [Related]
38. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
39. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
